Bio-Rad Laboratories, Inc. (BIO) Earnings Yield: 2.08%
Is Bio-Rad Laboratories, Inc.’s earnings yield high or low?
Bio-Rad Laboratories, Inc.'s earnings yield of 2.08% is 88% below its 5-year average of 17.02%, near the low end of its 5-year range (1.91%–39.06%).
The earnings yield for Bio-Rad Laboratories, Inc. (BIO) is 2.08% as of Wednesday, June 10, 2026. It is below its 12-month average by 64.61% (5.88%).
BIO Earnings Yield Chart
BIO Average Earnings Yield Chart
BIO Current vs Average Earnings Yield Chart
BIO Earnings Yield Metrics
EARNINGS YIELD
2.08%
EARNINGS YIELD AVG TTM
5.88%
EARNINGS YIELD AVG 3Y
5.88%
EARNINGS YIELD AVG 5Y
17.02%
EARNINGS YIELD AVG 10Y
9.95%
EARNINGS YIELD AVG 15Y
7.35%
EARNINGS YIELD AVG 20Y
6.55%
CURRENT VS TTM AVG
-64.61%
CURRENT VS 3Y AVG
-64.61%
CURRENT VS 5Y AVG
-87.78%
CURRENT VS 10Y AVG
-79.09%
CURRENT VS 15Y AVG
-71.71%
CURRENT VS 20Y AVG
-68.25%
BIO Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | — | 2.08% | 5.88% | 5.88% | 17.02% |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | N/A | 3.32% | 3.92% | 3.29% |
| Hims & Hers Health, Inc. (HIMS) | $6.42B | N/A | 1.75% | 1.50% | 1.50% |
| Align Technology, Inc. (ALGN) | $12.56B | 3.39% | 3.51% | 2.66% | 2.48% |
| Hologic, Inc. (HOLX) | $16.97B | 3.16% | 3.63% | 3.48% | 5.61% |
| Moderna, Inc. (MRNA) | $18.40B | N/A | 10.37% | 11.47% | 11.47% |
| BioNTech SE (BNTX) | $21.81B | N/A | 8.30% | 19.01% | 16.60% |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 3.77% | 3.16% | 3.10% | 2.84% |
| Waters Corporation (WAT) | $23.83B | 2.15% | 3.21% | 3.32% | 3.36% |
| Veeva Systems Inc. (VEEV) | $26.73B | 3.43% | 2.29% | 1.91% | 1.65% |
Earnings Yield vs P/E Ratio
Earnings Yield
2.08%
EPS ÷ Price
P/E Ratio
48.1
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Bio-Rad Laboratories, Inc. Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bio-Rad Laboratories, Inc. Earnings Yield FAQ
- What is the earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The earnings yield for BIO stock is 2.08%.
- Is Bio-Rad Laboratories, Inc.'s earnings yield high or low?
- Bio-Rad Laboratories, Inc.'s earnings yield of 2.08% is 88% below its 5-year average of 17.02%, near the low end of its 5-year range (1.91%–39.06%).
- What is the TTM average earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The TTM average earnings yield for BIO stock is 5.88%.
- What is the 3Y average earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The 3Y average earnings yield for BIO stock is 5.88%.
- What is the 5Y average earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The 5Y average earnings yield for BIO stock is 17.02%.
- What is the 10Y average earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The 10Y average earnings yield for BIO stock is 9.95%.
- What is the 15Y average earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The 15Y average earnings yield for BIO stock is 7.35%.
- What is the 20Y average earnings yield for Bio-Rad Laboratories, Inc. (BIO)?
- The 20Y average earnings yield for BIO stock is 6.55%.
Bio-Rad Laboratories, Inc. Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-10 | 2.08% |
| 2026-06-09 | 2.04% |
| 2026-06-08 | 2.08% |
| 2026-06-05 | 2.06% |
| 2026-06-04 | 1.97% |
| 2026-06-03 | 1.99% |
| 2026-06-02 | 1.98% |
| 2026-06-01 | 1.99% |
| 2026-05-29 | 1.94% |
| 2026-05-28 | 1.91% |
| 2026-05-27 | 1.99% |
| 2026-05-26 | 2.04% |
| 2026-05-22 | 2.11% |
| 2026-05-21 | 2.12% |
| 2026-05-20 | 2.11% |
| 2026-05-19 | 2.16% |
| 2026-05-18 | 2.15% |
| 2026-05-15 | 2.45% |
| 2026-05-14 | 2.46% |
| 2026-05-13 | 2.49% |
| 2026-05-12 | 2.51% |
| 2026-05-11 | 2.49% |
| 2026-05-08 | 2.39% |
| 2026-05-07 | 2.36% |
| 2026-05-06 | 2.34% |
| 2026-05-05 | 2.36% |
| 2026-05-04 | 2.35% |
| 2026-05-01 | 2.37% |
| 2026-04-30 | 2.17% |
| 2026-04-29 | 10.14% |
| 2026-04-28 | 9.99% |
| 2026-04-27 | 9.72% |
| 2026-04-24 | 9.70% |
| 2026-04-23 | 9.92% |
| 2026-04-22 | 9.28% |
| 2026-04-21 | 9.13% |
| 2026-04-20 | 9.20% |
| 2026-04-17 | 9.34% |
| 2026-04-16 | 9.59% |
| 2026-04-15 | 9.43% |
| 2026-04-14 | 9.55% |
| 2026-04-13 | 9.69% |
| 2026-04-10 | 9.99% |
| 2026-04-09 | 10.06% |
| 2026-04-08 | 9.93% |
| 2026-04-07 | 10.04% |
| 2026-04-06 | 10.01% |
| 2026-04-02 | 9.97% |
| 2026-04-01 | 10.03% |
| 2026-03-31 | 10.01% |
| 2026-03-30 | 10.32% |
| 2026-03-27 | 10.52% |
| 2026-03-26 | 10.09% |
| 2026-03-25 | 10.20% |
| 2026-03-24 | 10.26% |
| 2026-03-23 | 10.54% |
| 2026-03-20 | 10.55% |
| 2026-03-19 | 10.54% |
| 2026-03-18 | 10.42% |
| 2026-03-17 | 10.35% |
| 2026-03-16 | 10.68% |
| 2026-03-13 | 10.62% |
| 2026-03-12 | 10.66% |
| 2026-03-11 | 10.34% |
| 2026-03-10 | 10.42% |
| 2026-03-09 | 10.28% |
| 2026-03-06 | 10.34% |
| 2026-03-05 | 10.00% |
| 2026-03-04 | 9.80% |
| 2026-03-03 | 9.96% |
| 2026-03-02 | 9.98% |
| 2026-02-27 | 10.02% |
| 2026-02-26 | 10.14% |
| 2026-02-25 | 10.35% |
| 2026-02-24 | 10.38% |
| 2026-02-23 | 10.41% |
| 2026-02-20 | 10.29% |
| 2026-02-19 | 10.27% |
| 2026-02-18 | 10.31% |
| 2026-02-17 | 10.54% |
| 2026-02-13 | 10.88% |
| 2026-02-12 | 9.54% |
| 2025-10-28 | 3.55% |
| 2025-10-27 | 3.49% |
| 2025-10-24 | 3.45% |
| 2025-10-23 | 3.46% |
| 2025-10-22 | 3.51% |
| 2025-10-21 | 3.54% |
| 2025-10-20 | 3.64% |
| 2025-10-17 | 3.78% |
| 2025-10-16 | 3.76% |
| 2025-10-15 | 3.84% |
| 2025-10-14 | 3.84% |
| 2025-10-13 | 3.86% |
| 2025-10-10 | 3.94% |
| 2025-10-09 | 3.90% |
| 2025-10-08 | 3.87% |
| 2025-10-07 | 3.96% |
| 2025-10-06 | 3.79% |
| 2025-10-03 | 3.84% |
| 2025-10-02 | 3.99% |
| 2025-10-01 | 3.94% |
| 2025-09-30 | 4.18% |
| 2025-09-29 | 4.34% |
| 2025-09-26 | 4.32% |
| 2025-09-25 | 4.34% |
| 2025-09-24 | 4.24% |
| 2025-09-23 | 4.16% |
| 2025-09-22 | 4.14% |
| 2025-09-19 | 4.13% |
| 2025-09-18 | 4.10% |
| 2025-09-17 | 4.18% |
| 2025-09-16 | 4.16% |
| 2025-09-15 | 4.19% |
| 2025-09-12 | 4.18% |
| 2025-09-11 | 4.10% |
| 2025-09-10 | 4.24% |
| 2025-09-09 | 4.10% |
| 2025-09-08 | 4.04% |
| 2025-09-05 | 3.97% |
| 2025-09-04 | 4.05% |
| 2025-09-03 | 4.07% |
| 2025-09-02 | 4.04% |
| 2025-08-29 | 3.94% |
| 2025-08-28 | 3.99% |
| 2025-08-27 | 4.00% |
| 2025-08-26 | 3.95% |
| 2025-08-25 | 3.94% |
| 2025-08-22 | 3.86% |
| 2025-08-21 | 4.12% |
| 2025-08-20 | 4.07% |
| 2025-08-19 | 4.07% |
| 2025-08-18 | 4.12% |
| 2025-08-15 | 4.11% |
| 2025-08-14 | 4.08% |
| 2025-08-13 | 4.08% |
| 2025-08-12 | 4.27% |
| 2025-08-11 | 4.43% |
| 2025-08-08 | 4.44% |
| 2025-08-07 | 4.42% |
| 2025-08-06 | 4.44% |
| 2025-08-05 | 4.31% |
| 2025-08-04 | 4.24% |
| 2025-08-01 | 4.12% |
| 2025-07-31 | 4.85% |
| 2022-04-28 | 27.32% |
| 2022-04-27 | 27.93% |
| 2022-04-26 | 28.41% |
| 2022-04-25 | 26.46% |
| 2022-04-22 | 26.25% |
| 2022-04-21 | 25.71% |
| 2022-04-20 | 24.94% |
| 2022-04-19 | 25.19% |
| 2022-04-18 | 25.84% |
| 2022-04-14 | 25.58% |
| 2022-04-13 | 24.81% |
| 2022-04-12 | 25.06% |
| 2022-04-11 | 23.75% |
| 2022-04-08 | 23.47% |
| 2022-04-07 | 23.47% |
| 2022-04-06 | 24.27% |
| 2022-04-05 | 24.39% |
| 2022-04-04 | 24.57% |
| 2022-04-01 | 24.51% |
| 2022-03-31 | 24.88% |
| 2022-03-30 | 24.15% |
| 2022-03-29 | 24.10% |
| 2022-03-28 | 24.39% |
| 2022-03-25 | 24.81% |
| 2022-03-24 | 24.69% |
| 2022-03-23 | 24.75% |
| 2022-03-22 | 23.75% |
| 2022-03-21 | 24.15% |
| 2022-03-18 | 23.81% |
| 2022-03-17 | 24.39% |
| 2022-03-16 | 24.88% |
| 2022-03-15 | 25.51% |
| 2022-03-14 | 25.91% |
| 2022-03-11 | 26.46% |
| 2022-03-10 | 25.91% |
| 2022-03-09 | 25.25% |
| 2022-03-08 | 26.67% |
| 2022-03-07 | 25.45% |
| 2022-03-04 | 24.04% |
| 2022-03-03 | 22.99% |
| 2022-03-02 | 22.88% |
| 2022-03-01 | 22.73% |
| 2022-02-28 | 22.37% |
| 2022-02-25 | 21.83% |
| 2022-02-24 | 23.42% |
| 2022-02-23 | 24.45% |
| 2022-02-22 | 24.04% |
| 2022-02-18 | 23.98% |
| 2022-02-17 | 23.81% |
| 2022-02-16 | 22.88% |
| 2022-02-15 | 22.68% |
| 2022-02-14 | 22.57% |
| 2022-02-11 | 22.22% |
| 2022-02-10 | 35.21% |
| 2022-02-09 | 34.60% |
| 2022-02-08 | 35.71% |
| 2022-02-07 | 35.21% |
| 2022-02-04 | 35.21% |
| 2022-02-03 | 35.34% |
| 2022-02-02 | 35.59% |
| 2022-02-01 | 36.10% |
| 2022-01-31 | 36.76% |
| 2022-01-28 | 37.17% |
| 2022-01-27 | 39.06% |
| 2022-01-26 | 38.61% |
| 2022-01-25 | 38.31% |
| 2022-01-24 | 37.74% |
| 2022-01-21 | 37.59% |
| 2022-01-20 | 37.59% |
| 2022-01-19 | 36.90% |
| 2022-01-18 | 36.76% |
| 2022-01-14 | 35.09% |
| 2022-01-13 | 34.48% |
| 2022-01-12 | 32.89% |
| 2022-01-11 | 32.68% |
| 2022-01-10 | 33.22% |
| 2022-01-07 | 33.22% |
| 2022-01-06 | 32.26% |
| 2022-01-05 | 31.75% |
| 2022-01-04 | 31.45% |
| 2022-01-03 | 29.94% |
| 2021-12-31 | 29.15% |
| 2021-12-30 | 29.07% |
| 2021-12-29 | 29.33% |
| 2021-12-28 | 29.50% |
| 2021-12-27 | 28.82% |
| 2021-12-23 | 29.59% |
| 2021-12-22 | 29.67% |
| 2021-12-21 | 29.76% |
| 2021-12-20 | 30.30% |
| 2021-12-17 | 30.12% |
| 2021-12-16 | 30.03% |
| 2021-12-15 | 29.59% |
| 2021-12-14 | 30.49% |
| 2021-12-13 | 29.33% |
| 2021-12-10 | 29.59% |
| 2021-12-09 | 29.24% |
| 2021-12-08 | 28.65% |
| 2021-12-07 | 29.33% |
| 2021-12-06 | 29.67% |
| 2021-12-03 | 29.76% |
| 2021-12-02 | 29.50% |
| 2021-12-01 | 29.15% |
| 2021-11-30 | 29.24% |
| 2021-11-29 | 29.41% |
| 2021-11-26 | 29.41% |
| 2021-11-24 | 29.94% |
| 2021-11-23 | 29.76% |
| 2021-11-22 | 29.07% |
| 2021-11-19 | 28.41% |
| 2021-11-18 | 28.57% |
| 2021-11-17 | 28.25% |
| 2021-11-16 | 28.57% |
| 2021-11-15 | 29.24% |
| 2021-11-12 | 29.15% |
Showing the most recent 260 of 4,144 data points. The chart above shows the full history.
Related Metrics
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz